RBTI yields 3333333.33% · PFE yields 6.13%● Live data
📍 RBTI pulled ahead of the other in Year 1
Combined, RBTI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RBTI + PFE for your $10,000?
Red Branch Technologies, Inc., a technology holding company, engages in the development and commercialization of security and defense industry solutions. It offers The Mini that supports a combination of applications, such as mesh networks; The Mojo, which supports various applications, including video surveillance and long distance communications, as well as mesh networks; and The Titan that supports heavy amp applications, such as ground radar, thermal imaging, or satellite uplink for mobile security solutions. The company also provides TeleMax, tEODor-Robust bomb disposal robot, ODIS-T2 for omni-directional inspection, and multi-mission next generation ODIS-T2 for ordinance disposal and inspection. In addition, the company offers unmanned aerial vehicles, such as Long Star and XTS UAV for aerial surveillance. Its products are used in various applications, including disaster recovery; physical security; border, pipeline, and perimeter; wireless communication nets; forward operating bases; event security; humanitarian services; and water desalination, purification, pumping, as well as in military and law enforcement, and industrial-security/safety organizations. The company was incorporated in 1987 and is based in Ashburn, Virginia.
Full RBTI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.